CJC-1295 + Ipamorelin

What is CJC‑1295 + Ipamorelin?

CJC‑1295 is a growth hormone-releasing hormone (GHRH) analog, while Ipamorelin is a selective growth hormone secretagogue. Together, they act synergistically to stimulate endogenous growth hormone release via complementary pathways, supporting anabolic signaling and tissue repair. Research shows that combining these peptides may enhance growth hormone pulsatility and sustain signaling effects more effectively than either peptide alone.

What it does / research shows

Preclinical studies suggest that this combination may support lean tissue repair, promote protein synthesis, and enhance recovery signaling. Research indicates potential benefits for connective tissue, muscle maintenance, and adaptive regeneration under repeated physical stress. The combination is also studied for its ability to provide a more stable and prolonged increase in growth hormone activity compared with single-agent peptides.

Why motorcycle racers might find it interesting

Racers exposed to repeated muscular strain, joint stress, or minor injuries may find research into combined GH stimulation relevant for optimizing recovery, supporting lean tissue maintenance, and enhancing resilience under physical load.

Form & Use

Sold as a powder. To be reconstituted with bacteriostatic water before subcutaneous injection.

Disclaimer

Sold for research purposes only. Not FDA‑approved for therapeutic use. Not intended to diagnose, treat, cure, or prevent any disease or condition. Always consult a qualified healthcare professional before use. Contact us for consultation and purchase.